Sastasundar Ventures Ltd (HEALTHX) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Sastasundar Ventures Ltd. transitioned away from its partnership with Flipkart Health, leading to a strategic reset and renewed focus on its own B2C and B2B initiatives.
- RetailerShakti (B2B) demonstrated robust growth, nearly doubling its revenue from INR489 crores in FY24 to approximately INR941 crores in FY25.
- SastaSundar (B2C) generated INR144 crores in FY25, reflecting its nascent stage after the Flipkart Health transition.
- The company experienced a temporary dip in margins and negative EBITDA for FY25 due to the decline in B2C revenue and a largely unchanged fixed cost base.
- Sastasundar Ventures Ltd. is focused on executing its strategy of delivering seamless and affordable healthcare at scale by integrating digital innovation with a wide physical reach.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.